Security key
88338N206
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)
CUSIP: 88338N206
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 11,676,558
- Total 13F shares
- 3,408,566
- Share change
- +31,516
- Total reported value
- $5,487,879
- Put/Call ratio
- 1.1%
- Price per share
- $1.61
- Number of holders
- 34
- Value change
- -$167
- Number of buys
- 8
- Number of sells
- 19
Report period
Q2 2024
Institutions
34
Top holders
10
TXMD full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88338N206
Recent filing periods:
Top shareholders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP |
3/4/5
13F
|
Director, Other*, 10%+ Owner · Company |
10%
from 13F
|
2,946,908
|
$6,718,950 | — | 15 Nov 2023 | |
| Clearline Capital LP |
13F
|
Company |
4.6%
|
535,340
|
$1,225,929 | — | 31 Mar 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
3.4%
|
401,937
|
$920,436 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
387,582
|
$887,563 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
2.3%
|
272,160
|
$623,246 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
135,779
|
$310,934 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
131,692
|
$301,575 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.73%
|
84,788
|
$194,220 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
39,100
|
$89,539 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.26%
|
30,100
|
$68,929 | — | 31 Mar 2024 | |
| Clear Harbor Asset Management, LLC |
13F
|
Company |
0.22%
|
25,809
|
$59,103 | — | 31 Mar 2024 | |
| Prosperity Consulting Group, LLC |
13F
|
Company |
0.21%
|
24,500
|
$56,105 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.19%
|
22,470
|
$51,456 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
16,457
|
$37,687 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
13,700
|
$31,000 | — | 31 Mar 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
0.12%
|
13,562
|
$31,057 | — | 31 Mar 2024 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.1%
|
12,000
|
$27,480 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.09%
|
10,154
|
$23,253 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.07%
|
8,289
|
$18,982 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
7,814
|
$17,894 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
4,962
|
$11,363 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,637
|
$3,749 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,036
|
$2,371 | — | 31 Mar 2024 | |
| Cantonale Vaudoise Banque |
13F
|
Individual |
0.01%
|
1,000
|
$2,000 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.01%
|
720
|
$1,447 | — | 31 Mar 2024 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
410
|
$939 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
400
|
$916 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
363
|
$1,000 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
293
|
$671 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
267
|
$612 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
140
|
$320 | — | 31 Mar 2024 | |
| PRINCIPAL SECURITIES, INC. |
13F
|
Company |
0%
|
126
|
$289 | — | 31 Mar 2024 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
120
|
$275 | — | 31 Mar 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
60
|
$137 | — | 31 Mar 2024 | |
| Towne Trust Company, N.A |
13F
|
Company |
0%
|
50
|
$115 | — | 31 Mar 2024 | |
| Provenance Wealth Advisors, LLC |
13F
|
Company |
0%
|
20
|
$46 | — | 31 Mar 2024 | |
| BIRCHBROOK, INC. |
13F
|
Company |
0%
|
10
|
$23 | — | 31 Mar 2024 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
8
|
$18 | — | 31 Mar 2024 | |
| Guardian Wealth Management, Inc. |
13F
|
Company |
0%
|
2
|
$5 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
2
|
$5 | — | 31 Mar 2024 | |
| Aspire Private Capital, LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2024 | |
| ASSETMARK, INC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2024 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2024 | |
| John C.k. Milligan IV |
3/4/5
|
Secretary/CEO of subsidiary |
—
mixed-class rows
|
5,542,076
mixed-class rows
|
$12,698,322 | — | 10 May 2021 | |
| Hugh O'Dowd |
3/4/5
|
Chief Executive Officer |
—
mixed-class rows
|
4,250,000
mixed-class rows
|
$11,415,713 | — | 31 Mar 2022 | |
| Robert G. Finizio |
3/4/5
|
CEO, Director |
—
mixed-class rows
|
2,240,000
mixed-class rows
|
$5,305,888 | — | 01 Jul 2021 | |
| James Darecca |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
558,163
mixed-class rows
|
$1,857,402 | — | 10 Aug 2021 | |
| Edward Borkowski |
3/4/5
|
EVP, Operations |
—
mixed-class rows
|
560,000
mixed-class rows
|
$1,326,472 | — | 01 Jul 2021 | |
| J. Martin Carroll |
3/4/5
|
Director |
—
class O/S missing
|
106,864
|
$239,268 | — | 10 Aug 2021 | |
| Michael C. Donegan |
3/4/5
|
Prin. Fin. and Acctg. Officer |
—
class O/S missing
|
61,853
|
$138,489 | — | 12 Apr 2023 |
Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q2 2024
As of 30 Jun 2024,
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,408,566 shares.
The largest 10 holders included
Rubric Capital Management LP, Clearline Capital LP, Tejara Capital Ltd, VANGUARD GROUP INC, ADAR1 Capital Management, LLC, MORGAN STANLEY, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
43
Q2 2024 holders
34
Holder diff
-9
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.